KnowGovRepresentation. Influence. Action.
BillHR 9040 · 119

Regulate the Price of All Drugs Act

Introduced
May 26, 2026
Cosponsors
0
Traction
0
Last Action
May 26, 2026

Bill Summary

Regulates the price of all drugs, potentially limiting how much pharmaceutical companies can charge. Requires price controls on prescription medications.

Sponsored By

Brad Sherman
Democrat · California · House

Bill Journey

  1. May 26, 2026
  3. May 26, 2026You Are Here

    The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.

  4. TBD

    The full chamber debates the bill, may amend it, and votes on whether to pass it.

  5. TBD

    If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.

  6. TBD

    If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

This bill affects pharmaceutical companies, which may see reduced revenue, and consumers, who may have access to more affordable prescription medications. Patients relying on expensive medications could see a decrease in their out-of-pocket costs.

Impact Areas

Sample
Addresses Supply
Targets an underlying shortage driving costs.
Supports Families
Aimed at easing pressure on working households.
Long-term Impact
Effects compound across multiple budget cycles.
Expands Access
Lowers barriers for first-time participants.

Support & Opposition

Sponsor & cosponsor support by party
1backer
  • Democratic1
Cross-party cosponsors0 · 0%

Documents

1

Full text opens on congress.gov, the official source.

Bill Details

Bill TypeHouse Bill · Federal
Primary Topic—
CommitteeCommittee on Energy and Commerce
IntroducedMay 26, 2026
Last UpdatedMay 26, 2026
Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.